Egis Pharmaceuticals PLC · 66-66 · HUNGARY
For Egis Pharmaceuticals PLC · 66-66 · HUNGARY, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is HUNGARY; product code is 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen); date published is 09/30/2009; address is Kereszturi Ut 30-38 , Budapest, Budapest HUNGARY, verified against its source on 2026-09-16.
- Firm
- Egis Pharmaceuticals PLC verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- HUNGARY verified
- Address
- Kereszturi Ut 30-38 , Budapest, Budapest HUNGARY verified
- Date published
- 09/30/2009 verified
- Product code
- 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) verified
- FDA notes
- 11/2/2000 verified
What the source says
Egis Pharmaceuticals PLC Date Published : 09/30/2009 Kereszturi Ut 30-38 , Budapest, Budapest HUNGARY 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) Date Published: 09/30/2009 Notes: 11/2/2000
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.